Abstract
Abstract
Background
Repeated attacks of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) have been attributed to bacterial infections. However, sputum microbiology for identifying the bacteriological profile is not performed usually and remains controversial. Thus, we performed a prospective, cross-sectional study to assess the clinico-bacteriological profile of the patients with AECOPD and antibiotic resistance pattern of bacteria isolated from sputum samples. The study involved 104 consecutive hospitalized patients, of either gender, aged 40–90 years, and diagnosed with AECOPD. Before initiating an empirical antibiotic therapy, the sputum samples of all the patients were collected and subjected to Gram staining, bacterial culture, and antibiotic sensitivity.
Results
The most common bacterial isolates were P. aeruginosa (30.7%) followed by K. pneumoniae (20.3%) and S. pneumoniae (8.6%). Both Gram-positive and Gram-negative bacteria were most sensitive to Meropenem (91%) followed by Amoxicillin-clavulanic acid (83%). However, these bacteria were most resistant to Cefoperazone-sulbactam (43%) followed by Levofloxacin (41%). P. aeruginosa and K. pneumoniae were most resistant to Cefoperazone-sulbactam (23%) followed by Fluoroquinolones (23–35%), while S. pneumoniae was most resistant to Ciprofloxacin (44%) followed by Amoxicillin-clavulanic acid (33%).
Conclusions
Isolation of P. aeruginosa, as the most common agent, further confirms its roles in severe attacks of AECOPD. The regularly used antibiotics were found to be resistant to most isolates, thereby suggesting that severity of AECOPD may be attributed to the prevalence of antibiotic-resistant strains.
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Agusti A, Hogg JC (2019) Update on the pathogenesis of chronic obstructive pulmonary disease. N Engl J Med 381(13):1248–1256 https://doi.org/10.1056/NEJMra1900475
2. Lee J, Jung HM, Kim SK, Yoo KH, Jung KS, Lee SH et al (2019) Factors associated with chronic obstructive pulmonary disease exacerbation, based on big data analysis. Sci Rep 9(1):6679. https://doi.org/10.1038/s41598-019-43167-w
3. Global Initiative for Chronic Obstructive Lung Disease. Edition 2020. Available at: https://goldcopd.org/wp-content/uploads/2020/03/GOLD-2020-POCKET-GUIDE-ver1.0_FINAL-WMV.pdf [Accessed on 14 Mar 2021].
4. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R (2005) Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60(11):925–931. https://doi.org/10.1136/thx.2005.040527
5. Hogea SP, Tudorache E, Fildan AP, Fira-Mladinescu O, Marc M, Oancea C (2020) Risk factors of chronic obstructive pulmonary disease exacerbations. Clin Respir J 14(3):183–197. https://doi.org/10.1111/crj.13129
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献